# Minaris Regenerative Medicine, LLC – FDA Inspection, Jun 17, 2014

Source: https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/5a81bec9-2040-4d3a-a7ed-8fcfe398509d
Source feed: FDA_Inspections

> FDA inspection 886646 of Minaris Regenerative Medicine, LLC, June 17, 2014. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 886646
- Company Name: Minaris Regenerative Medicine, LLC
- Inspection Date: 2014-06-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1284408 - 2025-09-29](https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/9080b763-c431-455a-aed1-0c069db6f2aa)
- [FDA Inspection 1224145 - 2023-09-25](https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/67457ed3-fd4a-4ea8-9ff2-b34c5e919157)
- FDA Inspection 1101234 - 2019-08-26
- FDA Inspection 1020396 - 2017-04-26

Company: https://www.keypedia.com/companies/minaris-regenerative-medicine-llc/b5fdb186-e2e7-416c-b89e-66d15dbf5509

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
